This study, called EXER-MED, is looking at how exercise combined with a weight loss medication called tirzepatide affects weight and overall health. It aims to see if adding exercise helps more than just taking tirzepatide alone. You might be able to join if you are an adult between 30 and 65 years old and are considered overweight or have obesity. The study will measure your weight at the beginning and after 16 weeks to see the effects. Researchers also want to know if this combination improves other health factors like blood sugar, cholesterol, fitness, and quality of life. The study is currently unclear on its recruitment status.

Study design

This interventional study plans to enroll 24 participants to compare the effects of exercise plus tirzepatide versus tirzepatide alone.

What's involved

Participants will take tirzepatide for 16 weeks. If in the exercise group, you will exercise about 3 times a week at the University of Virginia for 16 weeks.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint, weight, is measured at 16 weeks, suggesting follow-up for at least that duration.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.